Security Snapshot

ZIMMER BIOMET HOLDINGS, INC. - Common Stock (ZBH) Institutional Ownership

CUSIP: 98956P102

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

731

Shares (Excl. Options)

148.77MFull value: 148,767,109 · shares · 30 Sep 2026

Price

$88.83

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0.01%
Share change
-3,178,814
Value change
-$280,395,981
Number of holders
731
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
192,997,880
SEC-reported price per share
$96.39
Insider filing price
$96.39
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • ZBH - ZIMMER BIOMET HOLDINGS, INC. - Common Stock is tracked under CUSIP 98956P102.
  • 731 institutions reported positions in Q3 2026.
  • 6 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 911 to 731 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $17.07BFull value: $17,067,481,064 · USD · 30 Jun 2026
    to
    $13.22BFull value: $13,217,238,116 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 731 institutions filings for Q3 2026.

Open SEC evidence

Security key

98956P102

13F reference period

Q3 2026

13F holders

731

13D/G owners

6

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
6
Security
ZBH
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
DODGE & COX 12% +12% $2,203,553,295 +$185,171,024 24,124,735 +9.2% Dodge & Cox 30 Jun 2026
BlackRock, Inc. 7.8% $1,580,678,480 15,573,187 BlackRock, Inc. 31 Mar 2025
VANGUARD CAPITAL MANAGEMENT LLC 7.5% $1,335,279,791 14,767,527 Vanguard Capital Management 31 Mar 2026
Capital International Investors 6.4% $1,136,120,350 12,438,366 Capital International Investors 30 Jun 2026
HARRIS ASSOCIATES L P 6.2% $1,102,842,094 12,264,703 HARRIS ASSOCIATES L P 31 Dec 2025
PRICE T ROWE ASSOCIATES INC /MD/ 4.1% $762,510,824 7,997,806 T. Rowe Price Associates, Inc. 31 Mar 2026
As of 30 Sep 2026, 731 institutional investors reported holding
148.77MFull value: 148,767,109 · shares · 30 Sep 2026
shares of ZIMMER BIOMET HOLDINGS, INC. - Common Stock (ZBH). This represents 77% of the company’s total
193MFull value: 192,997,880 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
58%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Dodge & Cox 12% 22,732,137 1.1% $2,019,295,730
VANGUARD CAPITAL MANAGEMENT LLC 6.5% 12,479,866 0.02% $1,108,586,497
HARRIS ASSOCIATES L P 6.3% 12,230,088 1.4% $1,086,398,685
Capital International Investors 5.6% 10,859,352 0.2% $964,636,238
STATE STREET CORP 4.6% 8,883,451 0.02% $791,212,240
VANGUARD PORTFOLIO MANAGEMENT LLC 4.2% 8,139,992 0.03% $723,075,489
GEODE CAPITAL MANAGEMENT, LLC 2.8% 5,387,130 0.02% $476,711,117
Invesco Ltd. 2.1% 4,128,790 0.03% $366,760,415
PRIMECAP MANAGEMENT CO/CA/ 2% 3,801,250 0.21% $337,665,038
VAN ECK ASSOCIATES CORP 1.8% 3,457,999 0.19% $307,174,051
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 1.4% 2,641,289 0.66% $234,625,702
DIMENSIONAL FUND ADVISORS LP 0.93% 1,800,316 0.03% $159,960,055
EQUITY INVESTMENT CORP 0.92% 1,776,758 3% $157,829,413
BANK OF AMERICA CORP /DE/ 0.76% 1,466,502 0.01% $130,269,353
Legal & General Group Plc 0.74% 1,431,354 0.03% $127,147,176
MANUFACTURERS LIFE INSURANCE COMPANY, THE 0.72% 1,391,546 0.1% $123,611,031
Thrivent Financial for Lutherans 0.65% 1,257,306 0.18% $111,686,000
Alyeska Investment Group, L.P. 0.61% 1,170,000 0.27% $103,931,100
VANGUARD FIDUCIARY TRUST CO 0.56% 1,077,125 0.02% $95,681,014
GOLDMAN SACHS GROUP INC 0.53% 1,021,307 0.01% $90,722,733
Holocene Advisors, LP 0.52% 1,006,656 0.21% $89,421,252
Freestone Grove Partners LP 0.52% 1,004,008 0.78% $89,186,031
RAYMOND JAMES FINANCIAL INC 0.46% 890,416 0.02% $79,095,668
Quantinno Capital Management LP 0.46% 887,922 0.07% $78,874,167
Sound Shore Management Inc /CT/ 0.41% 785,385 2.2% $69,765,750

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
51
Headline period
Q3 2026
Rows shown
1-25 of 51
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 148,767,109 $13,217,238,116 -$280,395,981 $88.83 731
2026 Q2 198,169,129 $17,067,481,064 +$506,498,562 $86.09 911
2026 Q1 192,212,230 $17,376,258,693 -$585,614,712 $90.42 916
2025 Q4 198,431,168 $17,858,124,751 +$619,797,170 $89.92 942
2025 Q3 191,176,947 $18,831,156,643 -$51,365,422 $98.50 959
2025 Q2 192,626,878 $17,571,714,234 +$792,544,334 $91.21 924
2025 Q1 182,679,026 $20,673,195,452 +$78,572,106 $113.18 989
2024 Q4 182,046,192 $19,223,206,496 -$24,425,238 $105.63 1,016
2024 Q3 180,798,566 $19,495,146,884 -$518,996,441 $107.95 970
2024 Q2 185,767,292 $20,157,286,081 +$84,265,168 $108.53 993
2024 Q1 184,944,590 $24,386,333,122 +$378,599,102 $131.98 1,001
2023 Q4 182,158,658 $22,167,115,854 -$108,284,800 $121.70 1,024
2023 Q3 183,160,339 $20,544,194,913 -$330,363,038 $112.22 1,007
2023 Q2 184,990,423 $26,912,517,176 +$79,651,340 $145.60 1,024
2023 Q1 184,640,260 $23,852,215,294 -$197,494,318 $129.20 983
2022 Q4 186,466,854 $23,771,585,025 +$15,032,266 $127.50 966
2022 Q3 187,764,427 $19,641,670,250 -$40,775,687 $104.55 902
2022 Q2 187,706,817 $19,721,444,102 -$182,677,512 $105.06 935
2022 Q1 190,563,833 $24,370,218,008 +$507,478,442 $127.90 950
2021 Q4 186,413,133 $23,689,681,090 -$291,970,620 $127.04 970
2021 Q3 186,211,587 $27,266,031,241 -$194,909,437 $146.36 964
2021 Q2 187,061,496 $30,082,557,789 +$495,687,147 $160.82 1,001
2021 Q1 186,359,556 $29,840,024,809 +$371,366,968 $160.08 1,009
2020 Q4 184,159,282 $28,376,620,252 +$233,718,901 $154.09 992
2020 Q3 183,057,491 $24,891,885,860 -$292,751,827 $136.14 915
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .